4/30/2026CDE Accepts Bayer Filing for FXIa Inhibitor Asundexian in Secondary St...

4/30/2026Former NMPA Deputy Commissioner Sentenced to 14 Years for Bribery

4/30/2026Livzon Takes Control of Vietnam's Imexpharm in $228M Deal

4/30/2026Vivacta Bio Raises $50M+ to Advance In Vivo CAR-T Platform into Clinic...

4/30/2026Kanova Raises Hundreds of Millions in New Round

4/29/2026CDE Seeks Feedback on Draft Bioanalytical Lab Compliance Report for Cl...

4/29/2026Samsung Bioepis Expands into China with ATLATL Partnership to Boost In...

4/29/2026Insilico Secures China IND Clearance for AI-Discovered IPF Drug Rentos...

4/29/2026CDE Opens Consultation on BNCT Drug Development Guideline

4/29/2026AstraZeneca Secures Dual First-Line Liver Cancer Approvals in China fo...

4/29/2026BeOne Expands Multispecific Pipeline With Potential $2B+ HuaHui Immuno...

4/29/2026Aureka Bio Raises $35M to Advance AI-Driven Antibody Discovery Platfor...

4/29/2026Mabwell Lists in Hong Kong in First "A-to-H 18A" Biotech Debut

4/28/2026China Moves to Expand Maternity Insurance Coverage in Draft Healthcare...

4/28/2026China Accelerates Biobank Buildout as Data Becomes Strategic Asset in ...

4/28/2026Sun Pharma's $11.75B Organon Deal Signals Major Push Into China Market

4/28/2026Gritgen Reports Durable Efficacy of Hemophilia A Gene Therapy at WFH 2...

4/28/2026QL Biopharma Files Hong Kong IPO to Advance Next-Gen Metabolic Pipelin...

4/28/2026Hengrui Launches Large-Scale Phase 3 Trial of GLP-1/GIP Agonist HRS953...

4/28/2026Seven Novel Drug Candidates Win IND Clearance in China Across Modaliti...

4/28/2026Simcere Withdraws and Plans Rapid Resubmission of Rademikibart NDA in ...

4/28/2026Theia Reports Early Clinical Progress for iPSC-Derived Cell Therapy in...

4/27/2026China's Basic Medical Insurance Fund Records Strong Surplus in Q1 2026

4/27/2026Former Jiangxi Provincial Health Commission Chief Dismissed/Investigat...

4/27/2026China NMPA Releases Updated Procedures for Conditional Drug Approvals

4/27/2026Adcoris Out-Licenses 5T4 ADC to NewCo in Global Deal with K2 Therapeut...

4/27/2026Novamab Raises ~CNY 300M Series B+ to Advance Inhaled and Oral Nanobod...

4/24/2026China Seeks Feedback on New Approval Framework for Clinical Translati...

4/24/2026CDE Issues New Framework for Post-Approval Changes and Registration Te...

4/24/2026Recent Executive Moves

Page:1/62 Total number of articles:1839: [First][<<] [1] [2] [3] [4] [5] [>>] [End]